Allogene Therapeutics, Inc. (ALLO): Shares Outstanding
229.41M
As of 2025-12-31
345.35M
As of 2026-06-30
+16.7%
3-year compound annual growth
+10.3%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 229.41M | +8.1% | 2026-03-12, Balance as of period end |
| 2024-12-31 | 212.21M | +25.8% | 2026-03-12, Balance as of period end |
| 2023-12-31 | 168.64M | n/a | 2025-03-13, Balance as of period end |
| 2023-09-30 | 168.18M | n/a | 2024-03-14, Balance as of period end |
| 2023-06-30 | 167.13M | n/a | 2024-03-14, Balance as of period end |
| 2023-03-31 | 145.74M | n/a | 2024-03-14, Balance as of period end |
| 2022-12-31 | 144.44M | n/a | 2024-03-14, Balance as of period end |
| 2022-09-30 | 144.03M | n/a | 2024-03-14, Balance as of period end |
| 2022-06-30 | 143.72M | n/a | 2024-03-14, Balance as of period end |
| 2022-03-31 | 143.57M | n/a | 2024-03-14, Balance as of period end |
| 2021-12-31 | 142.62M | +1.5% | 2024-03-14, Balance as of period end |
| 2020-12-31 | 140.47M | +13.0% | 2022-02-23, Balance as of period end |
| 2019-12-31 | 124.27M | +2.3% | 2021-02-25, Balance as of period end |
| 2018-12-31 | 121.48M | +362.8% | 2020-02-27, Balance as of period end |
| 2017-12-31 | 26.25M | n/a | 2019-03-08, Balance as of period end |